Literature DB >> 32116240

Performance evaluation of the Anysis-200 platelet function analyzer in cardiac patients.

Seong Jun Park1, Jung Yoon1, Hong Seog Seo2, Chae Seung Lim1.   

Abstract

BACKGROUND: Platelet function analysis is crucial in assessing the hemostatic status to evaluate congenital and acquired platelet function defects. The Anysis-200 analyzer is a new automated lab-on-a-chip-based platelet function analyzer.
OBJECTIVE: We aimed to evaluate a new platelet function analyzing system, the Anysis-200 in comparison to the Platelet Function Analyzer (PFA)-200 in cardiac patients.
METHODS: Citrated blood was collected from 174 patients who visited the Department of Cardiology. The Anysis-200 consists of two kits, the microchips with collagen and epinephrine-coated membrane (C/EPI) or adenosine diphosphate-coated membrane (C/ADP). Platelet clogging in the Anysis-200 is measured by the blood migration distance obtained by a camera, which is compatible with the closure time in the PFA-200. We performed Anysis-200 and PFA-200 analyzers simultaneously and compared the results.
RESULTS: The sensitivity and specificity of the Anysis-200 C/EPI kit in comparison to the PFA-200 C/EPI kit were 63.41% and 91.43%, respectively. Regarding the C/ADP kit, the sensitivity and specificity of the Anysis-200 were 58.97% and 74.29%, respectively. The agreement rate between the Anysis-200 and PFA-200 for C/EPI was 83.35% and 70.14% for C/ADP.
CONCLUSIONS: The Anysis-200, which applies a novel method to detect platelet clogging, has shown moderate to fair agreement with the PFA-200. This test is potentially useful for screening cardiac patients with an abnormal platelet function.

Entities:  

Keywords:  Anysis-200 analyzer; PFA-200 analyzer; Platelet function

Mesh:

Substances:

Year:  2022        PMID: 32116240     DOI: 10.3233/CH-190801

Source DB:  PubMed          Journal:  Clin Hemorheol Microcirc        ISSN: 1386-0291            Impact factor:   2.375


  2 in total

1.  Performance comparison of the PFA-200 and Anysis-200: Assessment of bleeding risk screening in cardiology patients.

Authors:  Jinxiang Piao; Chaeyoung Yoo; SunYoung Kim; Youn-Wha Whang; Cheol Ung Choi; Sehyun Shin
Journal:  Clin Hemorheol Microcirc       Date:  2021       Impact factor: 2.375

2.  Performance comparison of aspirin assay between Anysis and VerifyNow: Assessment of therapeutic platelet inhibition in patients with cardiac diseases.

Authors:  Jinxiang Piao; Chaeyoung Yoo; SeonYoung Kim; Youn-Wha Whang; Cheol Ung Choi; Sehyun Shin
Journal:  Clin Hemorheol Microcirc       Date:  2021       Impact factor: 2.375

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.